Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Cyclosporin administration improves clinical manifestations and quality of life in patients with 20-nail dystrophy: case series and survey study.

Lee YB, Cheon MS, Eun YS, Cho BK, Park YG, Park HJ.

J Dermatol. 2012 Dec;39(12):1064-5. doi: 10.1111/j.1346-8138.2012.01642.x. Epub 2012 Aug 20. No abstract available.

PMID:
22901077
2.

Topical cyclosporine versus emulsion vehicle for the treatment of brittle nails: a randomized controlled pilot study.

Mackay-Wiggan J, Marji J, Walt JG, Campbell A, Coppola C, Chakraborty B, Hollander DA, Whitcup SM.

J Drugs Dermatol. 2014 Oct;13(10):1232-9.

PMID:
25607558
3.

Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol.

Feliciani C, Zampetti A, Forleo P, Cerritelli L, Amerio P, Proietto G, Tulli A, Amerio P.

J Cutan Med Surg. 2004 Mar-Apr;8(2):122-5. Epub 2004 May 3.

PMID:
15129317
4.

Improvement of quality of life and clinical usefulness of cyclosporin administration in patients with nail psoriasis.

Abe M, Syuto T, Yokoyama Y, Ishikawa O.

J Dermatol. 2011 Sep;38(9):916-8. doi: 10.1111/j.1346-8138.2010.01104.x. Epub 2010 Nov 22. No abstract available.

PMID:
21352333
5.

Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study.

Cannavò SP, Guarneri F, Vaccaro M, Borgia F, Guarneri B.

Dermatology. 2003;206(2):153-6.

PMID:
12592084
6.

Instability of topical ciclosporin emulsion for nail psoriasis.

Prins AM, Vos K, Franssen EJ.

Dermatology. 2007;215(4):362-3. No abstract available.

PMID:
17911999
7.

Can median nail dystrophy be an adverse effect of alitretinoin treatment?

Winther AH, Bygum A.

Acta Derm Venereol. 2014 Nov;94(6):719-20. doi: 10.2340/00015555-1853. No abstract available.

8.

V-shaped, longitudinal nail dystrophies in trichorhinophalangeal syndrome type I.

Itin PH, Eich G, Fistarol SK.

Dermatology. 2005;211(2):162-4.

PMID:
16088167
9.

Nail findings in pemphigus vulgaris.

Lieb J, Levitt J, Sapadin AN.

Int J Dermatol. 2006 Feb;45(2):172-4. No abstract available.

PMID:
16445516
10.

Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy).

Sánchez-Regaña M, Sola-Ortigosa J, Alsina-Gibert M, Vidal-Fernández M, Umbert-Millet P.

J Eur Acad Dermatol Venereol. 2011 May;25(5):579-86. doi: 10.1111/j.1468-3083.2010.03938.x. Epub 2010 Dec 29.

PMID:
21198950
11.

A case of subcorneal pustular dermatosis treated successfully with a combination of cyclosporin and prednisolone.

Karadoğan SK, Aydoğan K, Başkan EB, Tunali S.

J Eur Acad Dermatol Venereol. 2007 Apr;21(4):536-7. No abstract available.

PMID:
17373984
12.

Topical calcipotriol therapy in nail psoriasis: a study of 24 cases.

Zakeri M, Valikhani M, Mortazavi H, Barzegari M.

Dermatol Online J. 2005 Dec 1;11(3):5.

13.

Severe resistant subacute prurigo successfully controlled by long-term cyclosporin.

Daudén E, García-Díez A.

J Dermatolog Treat. 2003 Jan;14(1):48-50.

PMID:
12745856
14.

Treatment of occupational koilonychia with tazarotene gel.

Hagman JH, Ginebri A, Mordenti C, De Simoni I, Chimenti S.

Acta Derm Venereol. 2003;83(4):296-7. No abstract available.

PMID:
12926806
15.

Plasma cell mucositis with oral and genital involvement - successful treatment with topical cyclosporin.

Heinemann C, Fischer T, Barta U, Michaelides A, Elsner P.

J Eur Acad Dermatol Venereol. 2006 Jul;20(6):739-40. No abstract available.

PMID:
16836510
16.

Pachyonychia congenita: treatment of the thickened nails and palmoplantar circumscribed callosities with urea 40% paste.

El-Darouti MA, Marzouk SA, Nabil N, Abdel-Halim MR, El-Komy MH, Abdel-Latif M.

J Eur Acad Dermatol Venereol. 2006 May;20(5):615-7. No abstract available.

PMID:
16684301
17.

Periungual lesions in pyoderma gangrenosum.

Reich A, Maj J, Cisło M, Szepietowski JC.

Clin Exp Dermatol. 2009 Jul;34(5):e81-4. doi: 10.1111/j.1365-2230.2009.03209.x. Epub 2009 May 5.

PMID:
19438552
18.

Nail psoriasis improvement in a patient treated with fumaric acid esters.

Vlachou C, Berth-Jones J.

J Dermatolog Treat. 2007;18(3):175-7.

PMID:
17538807
19.

Childhood nail psoriasis: a useful treatment with tazarotene 0.05%.

Diluvio L, Campione E, Paternò EJ, Mordenti C, El Hachem M, Chimenti S.

Pediatr Dermatol. 2007 May-Jun;24(3):332-3.

PMID:
17542899
20.

Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.

Rigopoulos D, Gregoriou S, Stratigos A, Larios G, Korfitis C, Papaioannou D, Antoniou C, Ioannides D.

Br J Dermatol. 2008 Aug;159(2):453-6. doi: 10.1111/j.1365-2133.2008.08686.x. Epub 2008 Jun 28.

PMID:
18565184
Items per page

Supplemental Content

Write to the Help Desk